Cargando…
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Several chronic viral infections (such as HIV and hepatitis C virus) are highly prevalent and are a serious health risk. The adaptation of animal viruses to the human host, as recently exemplified by influenza viruses and the severe acute respiratory syndrome coronavirus, is also a continuous threat...
Autor principal: | Balzarini, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098186/ https://www.ncbi.nlm.nih.gov/pubmed/17632570 http://dx.doi.org/10.1038/nrmicro1707 |
Ejemplares similares
-
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
por: Ilinykh, Philipp A., et al.
Publicado: (2018) -
Targeting the glycans of the HIV envelope as a therapeutic tool
por: Balzarini, Jan
Publicado: (2011) -
Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission
por: Mathys, Leen, et al.
Publicado: (2015) -
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023) -
Glycan analysis of therapeutic glycoproteins
por: Zhang, Lei, et al.
Publicado: (2015)